Mode
Text Size
Log in / Sign up

Mediterranean diet adherence is associated with reduced risk of several site-specific cancers and mortalityMediterranean diet linked to lower risk of several cancer types

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider the Mediterranean diet as a potential preventive strategy for reducing risks across multiple cancer types.

This systematic review and meta-analysis synthesized data from 126 studies involving more than 8 million participants to evaluate the association between Mediterranean diet (MD) adherence and various cancer outcomes. The analysis focused on site-specific cancers and cancer-related mortality.

The meta-analysis reported consistent risk reductions across multiple cancer types. Specifically, RR = 0.88 for head and neck cancer (95% CI 0.78-0.98), RR = 0.83 for oral cavity cancer (95% CI 0.73-0.95), RR = 0.93 for stomach cancer (95% CI 0.88-0.97), and RR = 0.94 for liver/gallbladder cancer (95% CI 0.93-0.96). Additionally, the analysis found reduced risks for colorectal cancer (RR = 0.95; 95% CI 0.92-0.98), bladder cancer (RR = 0.96; 95% CI 0.92-0.995), and breast cancer (RR = 0.95; 95% CI 0.92-0.98). Cancer-related mortality was also associated with a reduced risk (RR = 0.97; 95% CI 0.96-0.99).

The evidence for these primary outcomes is of moderate certainty. Because the included studies were observational, these results indicate associations rather than direct causation. These findings support the inclusion of Mediterranean diet promotion in public health policies as a preventive strategy.

How this fits prior evidence

This meta-analysis addresses a gap in nutritional prevention strategies by providing broad evidence for the protective associations of the Mediterranean diet across multiple cancer types. While previous coverage has focused on clinical markers like creatinine to cystatin C ratios, sarcopenia, and immunotherapy enhancers, this finding provides a large-scale overview of dietary impact on cancer risk and mortality.

When we think about how to protect our bodies from cancer, we often look for complex medical interventions. However, some of the strongest evidence might actually be found on our dinner plates. A massive review of 126 different studies involving over 8 million people looked at how a Mediterranean diet affects cancer risk.

The researchers found that people who stuck to this way of eating showed a lower risk for several specific types of cancer. This included head and neck, oral cavity, stomach, liver, bladder, and breast cancers. The data also suggested a lower risk of death from cancer overall.

While these results are encouraging, it is important to remember that these findings show an association rather than a direct cause. Because the data comes from many different studies rather than one single trial, we cannot say for certain how much the diet alone changes outcomes. It remains a strong piece of evidence for using nutrition as a tool in public health.

What this means for you:
A Mediterranean diet is linked to lower risks of several common cancers and cancer-related deaths.

Common questions

What types of cancer are linked to the Mediterranean diet?

The study found a reduced risk for several specific types of cancer. These included head and neck, oral cavity, stomach, liver/gallbladder, colorectal, bladder, and breast cancers.

How many people were included in this research?

This was a large-scale review that combined data from 126 different studies. These studies involved more than 8 million participants in total.

Does this mean the Mediterranean diet cures cancer?

No, the study shows an association between the diet and a lower risk of developing cancer or dying from it. It does not prove that the diet treats or cures existing cancer.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
BACKGROUND: The Mediterranean diet (MD), characterized by high consumption of plant-based foods, olive oil, moderate intake of fish and poultry, and limited red and processed meats, has been associated with various health benefits, but its role in cancer prevention remains under debate. METHODS: This review was conducted in accordance with PRISMA 2020 and MOOSE guidelines. A comprehensive search of PubMed/MEDLINE, Scopus, Embase, and Cochrane Library was performed up to February 28, 2024. Study quality was assessed using the Newcastle-Ottawa Scale, and the certainty of evidence was evaluated with the NUTRIGRADE approach. Pooled effect sizes were computed using a random-effects model and expressed as risk ratios (RR), hazard ratios, or odds ratios, as appropriate. RESULTS: A total of 126 studies, including more than 8 million participants, across all included studies, were included. High adherence to the MD, as one point increase in the adherence, was significantly associated with a modest reduced risk of several site-specific cancers, including head and neck (RR = 0.88, 95% CI 0.78-0.98), oral cavity (RR = 0.83, 95% CI 0.73-0.95), stomach (RR = 0.93, 95% CI 0.88-0.97), liver/gallbladder (RR = 0.94, 95% CI 0.93-0.96), colorectal (RR = 0.95, 95% CI 0.92-0.98), bladder (RR = 0.96, 95% CI 0.92-0.995), and breast cancer (RR = 0.95, 95% CI 0.92-0.98). Higher adherence was also associated with lower cancer-related mortality (RR = 0.97, 95% CI 0.96-0.99). Certainty of evidence was rated as moderate for the main outcomes. CONCLUSIONS: Greater adherence to the MD is associated with a lower risk of several site-specific cancers and reduced cancer mortality. These findings support the promotion of the MD as a preventive dietary strategy within public health policies.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.